Oncura improves prostate cryoablation technology

Cryotherapy developer Oncura introduced several enhancements to its prostate cancer cryotherapy technology at this month's American Urological Association meeting in San Francisco. Oncura is an independent business of Amersham, which was acquired by Waukesha, WI-based GE Healthcare in April.

The innovations include an increase in the size of the therapeutic ice ball generated by the firm's IceRod 17-gauge CryoNeedle, a new workstation, and other enhancements aimed at shortening the time required to perform prostate-cancer cryotherapy, Oncura said.

By AuntMinnie.com staff writers
May 20, 2004

Related Reading

Point/counterpoint: Prostate cancer researchers battle over treatment options, May 14, 2004

GE inks Italian RIS/PACS deal, May 4, 2004

GE Healthcare's Q1 sales, earnings grow, April 9, 2004

GE closes acquisition of Amersham, April 8, 2004

Copyright © 2004 AuntMinnie.com

Page 1 of 181
Next Page